Journal of the National Comprehensive Cancer Network · 2020 · 152 citations · 149 references
MedicineOncologyRadiation OncologyChemotherapyHematologic OncologyMedical OncologyCancer StagingChemotherapy In Hematologic MalignanciesLymphoma ImagingRadiation TherapyTherapy Response AssessmentToxicity ManagementClinical Practice Guidelines ImplementationHodgkin Lymphoma ImagingHodgkin Lymphoma TherapyHodgkin Lymphoma TreatmentLymphoma ChemotherapyLymphoma Treatment ResponseRestaging Of LymphomaTreatment Response Criteria
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.
149
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
Report of the Committee on Hodgkin's Disease Staging Classification.
Paul P. Carbone, Henry S. Kaplan, K. Musshoff et al. · PubMed · 1971 · 4.2K citations
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text
Medicine, Oncology, Pharmacology +17